Q-Line Biotech Ltd

NSE: QLINE · Healthcare · 8 announcements

Share price: ₹684.35
Market cap: ₹1,596 Cr
Revenue (annual): ₹341.7 Cr
Net profit (annual): ₹55.72 Cr
P/E (TTM): 28.6×Sector 53.1×
Promoter holding: 67.51%
FII holding: 1.67%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 2 Partnership 1 Financial Results 1 Board Meeting Outcome 1 Board Meeting Date 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

5 Sep 2026 17:43 IST NSE

Other Announcement

Q-Line Biotech Other Announcement

Q-Line Biotech Limited has re-appointed M/s. P S P & Associates as Cost Auditors for a 12-month term.

Execution: 12 months

Read the filing ↗

27 Jul 2026 18:49 IST NSE

Other Announcement

Q-Line Biotech Other Announcement

Q-Line Biotech Limited filed its quarterly Reconciliation of Share Capital Audit Report, as required under SEBI Regulation 76, for the quarter ended June 30, 2026.

Read the filing ↗